Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)

Card image cap

Phanes Therapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate PT886 in Combination with KEYTRUDA® (pembrolizumab)

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Canada , Ming Wang , Phanes Therapeutics Inc , Merck Co Inc , Merck Sharp Dohme , Prnewswire Phanes Therapeutics Inc , Announces Clinical Trial Collaboration , Supply Agreement , Merck Sharp , Phanes Therapeutics ,

comparemela.com © 2020. All Rights Reserved.